Herzuma 440 mg

Herzuma 440 mg is a cancer treatment medication containing trastuzumab. It is used to target specific proteins in certain types of cancer cells. This intravenous kit is manufactured by Celltrion Inc. in South Korea.

Herzuma 440 mg is primarily used in the treatment of specific types of cancer. It works by targeting and blocking the action of a protein called HER2, which is found in higher than normal amounts in some types of cancer cells. This medication is often used in combination with other cancer treatments to help slow or stop the growth of cancer cells. What is Herzuma used for? It is typically prescribed for breast cancer and stomach cancer that has spread to other parts of the body.

Common effects of Herzuma 440 mg may include fatigue, nausea, and vomiting. Some patients may also experience fever, chills, and weakness. These effects can vary from person to person and may not affect everyone who uses this medication.

Herzuma 440 mg should be handled with care and administered by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Herzuma 440 mg may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult with a healthcare professional before starting any new medication.